{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:21:28Z","timestamp":1788456088817,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Nebraska\u2013Lincoln ARD Hatch Act"},{"name":"Nebraska Tobacco Settlement Funds"},{"name":"Layman Seed Award"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bbalip.2015.12.001","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T11:48:50Z","timestamp":1450093730000},"page":"166-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-\u03b1-lipoic acid, in human hepatocellular carcinoma cells"],"prefix":"10.1016","volume":"1861","author":[{"given":"Joseph L.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjeza","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2015.12.001_bb0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2013.05.064","article-title":"Prevalence and trends of metabolic syndrome in the adult US population, 1999\u20132010","volume":"62","author":"Beltr\u00e1n-S\u00e1nchez","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2002-35403","article-title":"The complex role of triglycerides in cardiovascular disease","volume":"2","author":"Abdel-Maksoud","year":"2002","journal-title":"Semin. Vasc. Med."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0015","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"MTOR singaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","article-title":"Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways","volume":"14","author":"Yecies","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2009.09.058","article-title":"An emerging role of mTOR in lipid biosynthesis","volume":"19","author":"Laplante","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0045","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-61779-430-8_2","article-title":"Biochemical and pharmacological inhibition of mTOR by rapamycin and an ATP-competitive mTOR inhibitor","volume":"821","author":"Yu","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0055","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1600-6143.2008.02272.x","article-title":"Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients","volume":"8","author":"Kasiske","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0060","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.metabol.2006.01.017","article-title":"Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs","volume":"55","author":"Aggarwal","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(00)04209-4","article-title":"Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study","volume":"357","author":"Investigators","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0070","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0075","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3122\/jabfm.19.3.310","article-title":"Hypertriglyceridemia","volume":"19","author":"Pejic","year":"2006","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0085","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"NCEP","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/diacare.25.3.627","article-title":"Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes","volume":"25","author":"Vakkilainen","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0095","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2174\/1381612821666150105160059","article-title":"Phenylbutyric acid: simple structure\u2014multiple effects","volume":"21","author":"Kusaczuk","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0100","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymgme.2010.03.014","article-title":"Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control","volume":"100","author":"Lee","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117851","article-title":"Induction of peroxisomes by butyrate-producing probiotics","volume":"10","author":"Weng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3892\/ijmm.2013.1493","article-title":"The chemical chaperon 4-phenylbutyric acid ameliorates hepatic steatosis through inhibition of de novo lipogenesis in high-fructose-fed rats","volume":"32","author":"Ren","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0120","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1172\/JCI61248","article-title":"Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice","volume":"122","author":"Ai","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","article-title":"Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis","volume":"29","author":"Ozcan","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00446532","article-title":"Lipoic acid content of Escherichia coli and other microorganisms","volume":"106","author":"Herbert","year":"1975","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0014-5793(02)02589-9","article-title":"The biosynthetic pathway for lipoic acid is present in plastids and mitochondria in Arabidopsis thaliana","volume":"517","author":"Yasuno","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.abb.2009.01.024","article-title":"Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion","volume":"485","author":"Butler","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S0007114507876227","article-title":"Dietary lipoic acid-dependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats","volume":"100","author":"Huong","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0150","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00125-012-2530-4","article-title":"\u03b1-lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase","volume":"55","author":"Chen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0155","first-page":"2226","article-title":"Lipoic acid prevents liver metabolic changes induced by administration of a fructose-rich diet","volume":"2013","author":"Castro","year":"1830","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0160","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1152\/physiolgenomics.00138.2013","article-title":"Characterization of genome-wide transcriptional changes in liver and adipose tissues of ZDF (fa\/fa) rats fed R-\u03b1-lipoic acid by next-generation sequencing","volume":"45","author":"Pashaj","year":"2013","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090863","article-title":"Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese zucker rats","volume":"9","author":"Carrier","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/JCP.0b013e31816777f7","article-title":"A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia","volume":"28","author":"Kim","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0175","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/oby.2011.121","article-title":"Amelioration of lipid abnormalities by \u03b1-lipoic acid through antioxidative and anti-inflammatory effects","volume":"19","author":"Zhang","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm1061","article-title":"Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase","volume":"10","author":"Kim","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0185","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbrc.2005.05.035","article-title":"Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle","volume":"332","author":"Lee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2013.08.063","article-title":"Reversal of obesity-induced hypertriglyceridemia by (R)-\u03b1-lipoic acid in ZDF (fa\/fa) rats","volume":"439","author":"Yi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0195","first-page":"343","article-title":"The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects","volume":"12","author":"Carlson","year":"2007","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0200","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","article-title":"Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40","volume":"9","author":"Vander Haar","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0210","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0215","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1073\/pnas.0706517104","article-title":"Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance","volume":"104","author":"Tremblay","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0220","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2337\/diabetes.51.4.1233","article-title":"Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice","volume":"51","author":"Bartels","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0225","first-page":"1029","article-title":"Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice","volume":"119","author":"Han","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2796.2005.01556.x","article-title":"Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis","volume":"258","author":"Olofsson","year":"2005","journal-title":"J. Intern. Med."},{"issue":"Suppl","key":"10.1016\/j.bbalip.2015.12.001_bb0235","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1194\/jlr.R800090-JLR200","article-title":"The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism","volume":"50","author":"Ginsberg","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0240","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1172\/JCI119841","article-title":"Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes","volume":"100","author":"Kuipers","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0245","doi-asserted-by":"crossref","first-page":"26388","DOI":"10.1074\/jbc.273.41.26388","article-title":"Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia","volume":"273","author":"Huang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0250","first-page":"1844","article-title":"AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response","volume":"2014","author":"Li","year":"1842","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJHTS.S10547","article-title":"High content screening for nonclassical peroxisome proliferators","volume":"1","author":"Sexton","year":"2010","journal-title":"Int. J. High Throughput Screen."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0260","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11745-014-3964-x","article-title":"Alpha-lipoic acid supplementation reduces mTORC1 signaling in skeletal muscle from high fat fed, Obese Zucker Rats","volume":"49","author":"Li","year":"2014","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0265","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cmet.2012.05.002","article-title":"Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression","volume":"15","author":"Haas","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0270","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/embor.2013.5","article-title":"The multifaceted role of mTORC1 in the control of lipid metabolism","volume":"14","author":"Ricoult","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.advenzreg.2010.09.001","article-title":"Genetic ablation of S6-kinase does not prevent processing of SREBP1","volume":"51","author":"Lewis","year":"2011","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0290","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1194\/jlr.M020156","article-title":"The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and \u22122","volume":"53","author":"Qi","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0295","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1111\/j.1742-4658.2012.08684.x","article-title":"Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells","volume":"279","author":"Wurie","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0300","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0006-291X(02)02466-X","article-title":"Concerted elevation of acyl-coenzyme a:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin","volume":"298","author":"Meegalla","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121689","article-title":"Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia","volume":"451","author":"Zammit","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2011.07.038","article-title":"Role of S6K1 in regulation of SREBP1c expression in the liver","volume":"412","author":"Li","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0315","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4161\/auto.6.2.11062","article-title":"ER stress negatively regulates AKT\/TSC\/mTOR pathway to enhance autophagy","volume":"6","author":"Qin","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0320","series-title":"An Investigation of Mitochondrial Bioenergetics and the Turnover of Succinated Proteins in the Adipocyte During Diabetes","author":"Tanis","year":"2014"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0330","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0335","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sancak","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0340","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jnutbio.2011.11.011","article-title":"Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function","volume":"23","author":"Valdecantos","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0345","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbalip.2014.12.013","article-title":"alpha-Lipoic acid treatment increases mitochondrial biogenesis and promotes beige adipose features in subcutaneous adipocytes from overweight\/obese subjects","volume":"1851","author":"Fernandez-Galilea","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0350","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1210\/en.2003-0982","article-title":"Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status","volume":"144","author":"Hardie","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2015.12.001_bb0355","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1194\/jlr.M000992","article-title":"Prevention of high-fat diet-induced muscular lipid accumulation in rats by acid is not mediated by AMPK activation","volume":"51","author":"Timmers","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2015.12.001_bb0360","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198115002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198115002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T09:21:34Z","timestamp":1567416094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198115002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1388198115002152"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2015.12.001","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-\u03b1-lipoic acid, in human hepatocellular carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}